Israel tests coronavirus vaccine prototype on rodents at defense lab
Israel has begun testing a COVID-19 vaccine prototype on rodents at its bio-chemical defense laboratory, a source said on Tuesday.
Conclusion: The T-cell epitope-based peptide vaccine was designed for COVID-19 using the envelope protein as an immunogenic target. Nevertheless, the proposed vaccine rapidly needs to be validated clinically in order to ensure its safety and immunogenic profile to help stop this epidemic before it leads to devastating global outbreaks. PMID: 32461973 [PubMed - in process]
Russian scientists plan to start clinical trials within two weeks on a vaccine to combat the novel coronavirus, the country's health minister was quoted as saying on Saturday.
A Chinese-made coronavirus vaccine could be ready for market as early as the end of this year, China's State-owned Assets Supervision and Administration Commission (SASAC) said in a social media post.
Authors: Stefano ML, Kream RM, Stefano GB Abstract The emergence of the novel ß-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global pandemic of coronavirus disease 2019 (COVID-19). Clinical studies have documented that potentially severe neurological symptoms are associated with SARS-CoV-2 infection, thereby suggesting direct CNS penetration by the virus. Prior studies have demonstrated that the destructive neurological effects of rabies virus (RABV) infections are mediated by CNS transport of the virus tightly bound to the nicotinic acetylcholine receptor (nACh...
(Natural News) People across the globe are experiencing unprecedented levels of stress and anxiety as they struggle to cope with the fallout from the COVID-19 pandemic. While hundreds of thousands are mourning the loss of friends and family, millions more are reeling from the economic devastation that has resulted from the strict lockdown measures instituted...
Moderna Inc said on Friday it had started dosing patients in a mid-stage study with its experimental coronavirus vaccine and eventually plans to enroll 600 patients for the trial.
Scientists are developing drugs to stop the coronavirus. Here's what's promising and what isn't.
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
As the worldwide death toll from the novel coronavirus continues to rise, scientists across the globe are racing to find a vaccine.
Thirty-seven countries and the World Health Organization (WHO) appealed on Friday for common ownership of vaccines, medicines and diagnostic tools to tackle the global coronavirus pandemic, taking aim at patent laws they fear could become a barrier to sharing crucial supplies.